Mission Creek Capital Partners, Inc. Novartis Ag Transaction History

Mission Creek Capital Partners, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$83.5 - $98.47 $185,620 - $218,898	-2,223 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $5,855 - $7,082	-75 Reduced 3.26%	2,223 $210,000
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $12,321 - $13,650	-150 Reduced 6.13%	2,298 $200,000
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $8,093 - $9,110	-100 Reduced 3.92%	2,448 $214,000
Q1 2020 May 14, 2020	BUY	$70.67 - $99.01 $353 - $495	5 Added 0.2%	2,548 $210,000

Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $214,502 - $242,525	2,543 New	2,543 $241,000

1,346

140M

1.15M

866K

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Mission Creek Capital Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Mission Creek Capital Partners, Inc. with notifications on news.